相关实验视频

Updated: Jan 10, 2026

Preparation and Characterization of Lipophilic Doxorubicin Pro-drug Micelles

Preparation and Characterization of Lipophilic Doxorubicin Pro-drug Micelles

Published on: August 2, 2016

循环德克斯在脂质体中的疗法:进展和挑战

Petra Gerges¹, Raya Gerges¹, Paul Nguewa²

¹Faculty of Medicine, American University of Beirut, Lebanon.

Carbohydrate polymers

|November 22, 2025

概括

环极在脂质体 (CLs) 通过克服环极和脂质体的局限性来增强药物输送. 这些先进的载体提高了生物可用性,并使针对各种疾病的向输送成为可能.

科学领域:

纳米技术纳米技术
制药科学制药科学
药物输送系统药物输送系统

背景情况:

环极素 (CDs) 是有效的溶解剂,但其口服生物可用性较差,并迅速解离.
脂质体可以封装疏水药物,但面临着膜稳定性和低负载率的挑战.
药物-在-环氧化-在-脂质体 (DCLs) 被引入,以结合CDs和脂质体的好处.

研究的目的:

审查CD-in-liposomes (CLs) 作为药物输送载体的优势.
探索CL和DCL在运输免费CD或CD/药物复合物的潜力.
总结关于基于CL和DCL的疾病治疗配方及其机制的文献.

主要方法:

关于CL和DCL的科学出版物的文献综述.
分析环氧和脂质体技术的进步.
检查药物负载,稳定性,向和体内分发机制.

主要成果:

与独立CD相比,CL提供了更好的生物可用性和受控释放.
脂质体能够进行表面修改以进行有针对性的传递,这仅仅是CD的挑战.
通过提高药物的疗效和减少副作用,CL和DCL在治疗各种疾病方面表现有前途.

结论:

CD-in-liposomes代表了药物输送的重大进步,克服了单个成分的局限性.
这些纳米载体为溶解疏水药物提供了多功能平台,并使其能够有针对性地输送.
对CL和DCL配方的进一步研究为新的治疗策略提供了巨大的潜力.

关键词:

胆固醇胆固醇胆固醇循环德克斯特林 (Cyclodextrin) 是一种循环德克斯特林.在脂质体内含有循环德克斯特林.药物-在-循环odextrin-在-脂质体中的药物.脂质滴滴是指脂质的滴滴.脂质细胞体中的脂肪体.

更多相关视频

Preparation and Characterization of Nanoliposomes for the Entrapment of Bioactive Hydrophilic Globular Proteins

Preparation and Characterization of Nanoliposomes for the Entrapment of Bioactive Hydrophilic Globular Proteins

Published on: August 31, 2019

Uptake of New Lipid-coated Nanoparticles Containing Falcarindiol by Human Mesenchymal Stem Cells

Uptake of New Lipid-coated Nanoparticles Containing Falcarindiol by Human Mesenchymal Stem Cells

Published on: February 9, 2019

相关概念视频

Bioavailability Enhancement: Drug Permeability Enhancement

Bioavailability Enhancement: Drug Permeability Enhancement

Body:After oral administration, poor permeability often limits the rate at which drugs are absorbed through the intestinal epithelium. Enhancing drug permeability is crucial for effective therapy, and several strategies have been developed to overcome this challenge.One effective strategy involves the use of lipid-based formulations. These formulations enhance dissolution and solubility, targeting physiological mechanisms to increase drug absorption. This includes stimulating bile salt...

Bioavailability Enhancement: Drug Stability Enhancement and GI Retention

Bioavailability Enhancement: Drug Stability Enhancement and GI Retention

Body:Improving a drug's stability in the gastrointestinal (GI) tract is paramount for enhancing its bioavailability and therapeutic effectiveness. Various strategies are employed to protect the drug from the harsh gastric milieu and to ensure its release and absorption at the desired site within the GI tract.Polymer coatings are one such method used to shield drugs from the stomach's acidic environment. By preventing premature drug release, these coatings improve the bioavailability of unstable...

Bioavailability Enhancement: Drug Solubility Enhancement

Bioavailability Enhancement: Drug Solubility Enhancement

Body:Bioavailability is a critical factor in determining a drug's effectiveness. It refers to the proportion of a drug that enters the circulation when introduced into the body and is, as a result, able to have an active effect. Enhancing bioavailability is essential for drugs with poor solubility, as it can significantly impact their therapeutic efficacy. Various methods are employed to increase the solubility of drugs, thereby enhancing their bioavailability.Micronization and nanonization are...